Skip to main content
Figure 1 | BMC Medicine

Figure 1

From: A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Figure 1

Nomogram to calculate the risk of prostate cancer on biopsy. All markers are given in nanograms per milliliter, except for human kallikrein 2, which is given in 10 pg/ml. The model can be used for a man with elevated prostate specific antigen (PSA) at his first PSA test. tPSA, total PSA; fPSA, free PSA; iPSA, intact PSA.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us